CETTA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 470
AS - Asia 428
EU - Europa 221
SA - Sud America 87
AF - Africa 9
Totale 1.215
Nazione #
US - Stati Uniti d'America 448
SG - Singapore 172
CN - Cina 124
IT - Italia 88
BR - Brasile 74
HK - Hong Kong 54
DE - Germania 26
VN - Vietnam 23
FI - Finlandia 21
GB - Regno Unito 20
IN - India 18
SE - Svezia 17
CA - Canada 14
RU - Federazione Russa 10
PL - Polonia 9
MX - Messico 8
TR - Turchia 8
JP - Giappone 7
NL - Olanda 7
AR - Argentina 6
ZA - Sudafrica 6
EC - Ecuador 5
BD - Bangladesh 4
ES - Italia 4
IR - Iran 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
ID - Indonesia 3
IE - Irlanda 3
BG - Bulgaria 2
CH - Svizzera 2
FR - Francia 2
IQ - Iraq 2
PK - Pakistan 2
UA - Ucraina 2
AT - Austria 1
BW - Botswana 1
CO - Colombia 1
GH - Ghana 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
NG - Nigeria 1
VE - Venezuela 1
Totale 1.215
Città #
Dallas 151
Singapore 103
Hong Kong 54
Ashburn 49
New York 35
Beijing 32
Milan 23
Hefei 18
Shanghai 18
Los Angeles 16
Boardman 11
Florence 10
São Paulo 10
Turku 10
Denver 9
Munich 9
Nuremberg 9
Warsaw 9
Ho Chi Minh City 8
Ankara 7
Orem 7
Chennai 6
Houston 6
Santa Clara 6
Tokyo 6
Helsinki 5
Lappeenranta 5
Montreal 5
Poplar 5
Rho 5
Atlanta 4
Coimbatore 4
Johannesburg 4
Mexico City 4
Rome 4
Seattle 4
Stockholm 4
Tehran 4
Toronto 4
Amsterdam 3
Belo Horizonte 3
Bologna 3
Brussels 3
Dublin 3
Falkenstein 3
Hackney 3
Lawrence 3
Manchester 3
Perugia 3
Phoenix 3
Princeton 3
Washington 3
Betim 2
Biên Hòa 2
Brooklyn 2
Charlotte 2
Curitiba 2
Hanoi 2
Hải Dương 2
Itaúna 2
Jiaxing 2
Limeira 2
Miami 2
Moscow 2
Nantong 2
Naples 2
New Delhi 2
Ottawa 2
Pescara 2
Quito 2
Recife 2
San Cipriano d'Aversa 2
San Francisco 2
Sofia 2
Teixeira de Freitas 2
Thủ Đức 2
Tianjin 2
Turin 2
Xi'an 2
Acarigua 1
Al Fujairah City 1
Alto Santo 1
Annapolis 1
Arapiraca 1
Bacabal 1
Baie-D'Urfé 1
Balcarce 1
Bexley 1
Bishkek 1
Bismarck 1
Boston 1
Brasília 1
Buenos Aires 1
Camden 1
Cao Lanh 1
Cape Town 1
Capão da Canoa 1
Castanhal 1
Chicago 1
Choele Choel 1
Totale 797
Nome #
A novel scoring approach to identify responders to erenumab in clinical practice 152
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 82
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 80
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 76
Imaging the brain and vascular reactions to headache treatments: a systematic review 75
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 73
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study 65
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 62
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 61
Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report 61
Stress in paediatric migraine: a trigger factor? 59
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study (Journal of Neurology, (2024), 271, 5, (2434-2443), 10.1007/s00415-023-12103-4) 57
Tracking the evolution of non-headache symptoms through the migraine attack 56
Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report 54
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study 43
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x) 42
Erenumab effect on brain network function in episodic migraine patients: a randomized, placebo-controlled, clinical trial 42
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x) 39
A novel scoring approach to identify responders to erenumab in clinical practice 33
An Altered Hypothalamic-Pontine Functional Interplay Could Affect Migraine Disease Progression Over the Years 32
Clinical and neuroradiological evolution of thymoma-associated anti-GABAA receptor autoimmune encephalitis: insights from a clinical case report 19
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) 16
Totale 1.279
Categoria #
all - tutte 6.219
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.219


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 1 0 0 0 0 0 0
2021/20228 0 1 1 0 0 0 0 0 0 0 5 1
2022/202352 8 6 7 0 3 3 2 2 3 0 3 15
2023/2024161 7 16 16 14 13 27 3 16 4 4 19 22
2024/2025321 24 6 19 14 32 23 35 23 36 47 34 28
2025/2026736 97 97 139 219 140 44 0 0 0 0 0 0
Totale 1.279